SCHEMBL20543183

SCHEMBL20543183

C=CCCCCCC/C=C\C/C=C\CCCCC

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.73
TRPV1 Q8NER1 1/20 0.57
ALDH1A1 P00352 5/20 0.56
KDM4E B2RXH2 3/20 0.55
F7 P08709 3/20 0.55
F3 P13726 3/20 0.55
PPARG P37231 2/20 0.55
PPARD Q03181 2/20 0.55
PPARA Q07869 2/20 0.55
FABP3 P05413 2/20 0.55
DUSP3 P51452 1/20 0.55
PTPN7 P35236 1/20 0.55
FFAR1 O14842 1/20 0.55
LMNA P02545 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP19A1 P11511 1/20 0.55
FABP4 P15090 1/20 0.55
HPGD P15428 1/20 0.55
ALOX15 P16050 1/20 0.55
PTGS1 P23219 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11073304 1.00 TSHR (0.73) TSHRTRPV1ALDH1A1KDM4EF7
SCHEMBL30605577 1.00 TSHR (0.73) TSHRTRPV1ALDH1A1KDM4EF7
SCHEMBL29869078 1.00 TSHR (0.73) TSHRTRPV1ALDH1A1KDM4EF7
SCHEMBL11073391 1.00 TSHR (0.73) TSHRTRPV1ALDH1A1KDM4EF7
SCHEMBL11073390 1.00 TSHR (0.73) TSHRTRPV1ALDH1A1KDM4EF7
SCHEMBL1296303 1.00 TSHR (0.73) TSHRTRPV1ALDH1A1KDM4EF7
SCHEMBL9155807 1.00 TSHR (0.73) TSHRTRPV1ALDH1A1KDM4EF7
SCHEMBL1296302 1.00 TSHR (0.73) TSHRTRPV1ALDH1A1KDM4EF7
SCHEMBL9155814 1.00 TSHR (0.73) TSHRTRPV1ALDH1A1KDM4EF7
SCHEMBL25185268 0.98 TSHR (0.70) TSHRTRPV1ALDH1A1KDM4EF7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11471533-B2 Compound usable as cationic lipid KYOWA KIRIN CO., LTD. (JP) 2022-10-18 US disclosed
EP-3521270-B1 CATIONIC LIPID COMPOUND KYOWA KIRIN CO LTD (JP) 2022-06-29 EP disclosed
US-20210275672-A1 COMPOUND USABLE AS CATIONIC LIPID KYOWA HAKKO KIRIN CO., LTD. (JP) 2021-09-09 US disclosed
US-20200368173-A1 NUCLEIC ACID-CONTAINING LIPID NANOPARTICLE KYOWA KIRIN CO., LTD. (JP) 2020-11-26 US disclosed
EP-3662913-A1 NUCLEIC-ACID-CONTAINING LIPID NANOPARTICLES Kyowa Kirin Co., Ltd. (JP) 2020-06-10 EP disclosed
EP-3521270-A1 CATIONIC LIPID COMPOUND Kyowa Hakko Kirin Co., Ltd. (JP) 2019-08-07 EP disclosed
US-20190008975-A1 COMPOUND AS CATIONIC LIPID KYOWA HAKKO KIRIN CO., LTD. (JP) 2019-01-10 US disclosed
EP-3395797-A1 COMPOUNDS AS CATIONIC LIPIDS Kyowa Hakko Kirin Co., Ltd. (JP) 2018-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11471533-B2 Compound usable as cationic lipid NPC1L1, PLIN1, PLIN5 TSHR 3958/4885TRPV1 834/4885ALDH1A1 3708/4885
US-20210275672-A1 COMPOUND USABLE AS CATIONIC LIPID NPC1L1, PLIN1, PLIN5 TSHR 3958/4885TRPV1 834/4885ALDH1A1 3708/4885
US-20190008975-A1 COMPOUND AS CATIONIC LIPID NPC1L1, LIPA, CETP TSHR 2967/4885TRPV1 314/4885ALDH1A1 2340/4885
US-20200368173-A1 NUCLEIC ACID-CONTAINING LIPID NANOPARTICLE LIPA, LIPC, PNLIP TSHR 3238/4885TRPV1 3502/4885ALDH1A1 354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.